The short version
What teams need to understand
- Pharmacovigilance systems must define clear roles and responsibilities across all activities.
- Responsibilities must be allocated across global, local, and functional roles.
- Accountability must be clearly defined, with no gaps or overlaps in responsibility.
- Roles must reflect actual operational practice and regulatory obligations.
- Authority and decision-making responsibility must be documented.
- Inspection-ready evidence must demonstrate that PV roles are defined, understood, and implemented.
Regulatory expectation
What regulators expect
Each expectation should be supported by controlled documentation, traceable records, clear ownership, and evidence that the process works in practice.
- All pharmacovigilance activities must have clearly defined ownership.
- Responsibilities must be allocated without gaps or ambiguity.
- Authority for decision-making must be documented.
- Roles must align with actual operational practice.
- The PV system must be supported by a defined organisational structure.
Why it matters
What this means in practice
Inspectors assess whether pharmacovigilance systems define clear roles and responsibilities across all functions. They typically review role definitions, accountability structures, authority levels, and evidence that responsibilities are aligned with actual practice.
Questions this page answers
Inspection evidence
Evidence teams should be able to show
PV Roles and Responsibilities SOP
- Defined PV organisational structure
- Role descriptions across all PV functions
- Clear allocation of responsibilities
- Defined authority and reporting lines
Role Description Documents
- Job descriptions for PV roles
- Defined responsibilities for each role
- Required qualifications and competencies
- Defined authority and decision-making scope
Organisational Role Matrix
- Mapping of responsibilities across functions
- Global versus local role allocation
- Interaction between PV, QA, Regulatory, and Medical roles
- Identification of ownership for each PV activity
Governance and Oversight Structure
- Defined reporting lines to QPPV
- Escalation pathways for safety issues
- Committee or governance structures
- Evidence of oversight responsibility
Delegation and Backup Coverage
- Deputy roles and backup assignments
- Delegation logs for temporary responsibility transfer
- Documentation of role substitution during absence
- Evidence of continuous coverage of PV activities
Regulatory Basis (Primary Sources)
- GVP Module I - requirement for defined pharmacovigilance roles and responsibilities
- GVP Module VI - responsibilities for ICSR handling and reporting
- ICH E2D - expectations for structured safety data management responsibilities
- MHRA GPvP guidance - expectations for PV organisational structure
- FDA pharmacovigilance guidance - requirement for defined responsibilities and accountability
Typical Inspection Questions (What Inspectors Ask)
- Who is responsible for pharmacovigilance in your organisation?
- How are responsibilities allocated across your PV system?
- Show me your PV organisational structure.
- How do you ensure there are no gaps in responsibility?
- How are responsibilities managed during absence or delegation?
Common failure patterns
What good looks like
- A clearly defined PV organisational structure.
- Documented roles and responsibilities for all PV activities.
- Clear ownership and accountability across functions.
- Defined authority and escalation pathways.
- Alignment between documented roles and operational practice.
How teams operationalise it
- Define PV roles and responsibilities within an SOP.
- Create role descriptions for each PV function.
- Develop a role matrix mapping activities to ownership.
- Ensure alignment between global and local responsibilities.
- Define authority and escalation pathways.
- Implement backup and delegation processes.
From expectation to working control
Find the documentation that supports this work
Review the related toolkit to understand its purpose, included files, and how it supports this regulatory expectation.
Frequently asked questions
What is a pharmacovigilance roles and responsibilities framework?
It is a structured definition of all roles, responsibilities, and authority across the PV system to ensure accountability and compliance.
What are the key roles in pharmacovigilance?
Key pharmacovigilance roles typically include the QPPV, local safety officers, PV operations staff, safety physicians, quality assurance personnel, and regulatory affairs functions, each responsible for specific aspects of safety monitoring, reporting, and compliance.
Why are roles and responsibilities important in pharmacovigilance?
Clear roles ensure that all safety activities are owned, performed correctly, and compliant with regulatory requirements.
Who is responsible for pharmacovigilance activities?
Responsibility is shared across multiple roles, but ultimate accountability typically sits with the QPPV and the MAH.
Do inspectors review PV roles and responsibilities?
Yes. Inspectors review role definitions, organisational structures, and accountability to ensure compliance.
What happens if responsibilities are unclear?
Unclear responsibilities can lead to inspection findings due to gaps, duplication, or failure to perform critical activities.
How do you ensure continuous coverage of PV responsibilities?
Through defined backup roles, delegation processes, and clear assignment of responsibilities across the organisation.
Source boundary
Regulatory sources
These primary sources inform this structured interpretation. Always confirm current requirements against the original source and the requirements applicable to your organisation, product, and jurisdiction.
European Medicines Agency (EMA)
Guideline on good pharmacovigilance practices (GVP) - Module I
View sourceGuideline on good pharmacovigilance practices (GVP) - Module VI
View source
FDA
Postmarketing Safety Reporting
View source
ICH
Post-Approval Safety Data Management (E2D)
View source
MHRA
Good Pharmacovigilance Practice (GPvP)
View source